Associate Director, Search & Evaluation

The Novo Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas.

Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve.

The Novo Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas.

Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve.

Global Business Development is responsible for Novo corporate business development activities related to establishing external partnerships, collaborations and acquisitions, as well as integration and alliance management. The Group Vice President (GVP) area consists of units covering business development from end-to-end with Search, Evaluation & Intelligence, BD and M&A Transactions, Integration and Alliance Management. Search, Evaluation & Intelligence (SE&I) is part of GBD and acts as the primary entry point for external drug and technology opportunities relevant to Novo.

SE&I conducts proactive scouting campaigns to identify relevant opportunities by targeting universities, biotechnology companies and venture capital firms, by means of partnering events, road shows and commissioned meetings or events. The search for novel therapeutics focuses on our core areas: diabetes, obesity, as well as MASH, CVD CKD and rare blood and endocrine disorders. Besides our therapeutic areas of interest, SE&I supports the identification of cutting-edge enabling technologies within oligonucleotides, protein and peptide engineering and gene editing/therapy.

Working cross-functionally, SE&I supports the assessment of such external opportunities all the way to due diligence and contractual negotiation.

The position is part of the global SE&I evaluation team with members located predominantly in Denmark and Cambridge, MA, US. Reports to the Sr. Director, Global Evaluation. The role will interact cross-functionally with stakeholders from the entire value chain while working in close collaboration with Novo Business Development teams located in Denmark and Cambridge. This position will also leverage their networks and actively engage with external stakeholders including biotech companies, venture capital firms and large-cap pharma communities.

The role has no direct or indirect reports.

• Contribute to and support identification of novel pipeline assets and enabling technologies
• Drive in-depth evaluation and due diligence process
• Establish Novo as the preferred partner within relevant therapy areas
• Provide support to Business Development during…